Kukje Pharma Co Ltd Total Liabilities
Kukje Pharma Co Ltd total liabilities. Based on the latest financial reports, Kukje Pharma Co Ltd (002720) has total liabilities worth ₩84.80 Billion KRW (≈ $57.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Kukje Pharma Co Ltd (002720) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Kukje Pharma Co Ltd (2011–2024)
Total liabilities of Kukje Pharma Co Ltd from 2011 to 2024. This chart illustrates how Kukje Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Kukje Pharma Co Ltd to see how much of total assets are deployed in long-term investments.
Kukje Pharma Co Ltd Competitors by Total Liabilities
The table below lists competitors of Kukje Pharma Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bali Bintang Sejahtera Tbk PT
JK:BOLA
|
Indonesia | Rp129.33 Billion |
|
Euro Sun Mining Inc
TO:ESM
|
Canada | CA$7.09 Million |
|
Delta Technologies Nyrt
BUD:DELTA
|
Hungary | Ft10.84 Billion |
|
Annovis Bio Inc
NYSE:ANVS
|
USA | $13.12 Million |
|
Do Day Dream Public Company Limited
BK:DDD
|
Thailand | ฿309.00 Million |
|
SAMYOUNG M-Tek Co. Ltd
KQ:054540
|
Korea | ₩327.62 Billion |
|
Supra Boga Lestari Tbk
JK:RANC
|
Indonesia | Rp911.49 Billion |
|
Beijing North Star Company Limited
F:BJ3
|
Germany | €33.63 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Kukje Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Kukje Pharma Co Ltd (002720) total assets.
Liquidity & Leverage Metrics
Kukje Pharma Co Ltd Total Liabilities Ratios Explained
Kukje Pharma Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kukje Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kukje Pharma Co Ltd (2011–2024)
The table below shows the annual total liabilities of Kukje Pharma Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩76.00 Billion ≈ $51.50 Million |
-2.95% |
| 2023-12-31 | ₩78.31 Billion ≈ $53.07 Million |
+25.27% |
| 2022-12-31 | ₩62.51 Billion ≈ $42.36 Million |
-12.19% |
| 2021-12-31 | ₩71.20 Billion ≈ $48.25 Million |
-5.23% |
| 2020-12-31 | ₩75.13 Billion ≈ $50.91 Million |
+2.02% |
| 2019-12-31 | ₩73.64 Billion ≈ $49.90 Million |
+27.99% |
| 2018-12-31 | ₩57.54 Billion ≈ $38.99 Million |
-9.91% |
| 2017-12-31 | ₩63.87 Billion ≈ $43.28 Million |
+3.12% |
| 2016-12-31 | ₩61.94 Billion ≈ $41.97 Million |
-9.16% |
| 2015-12-31 | ₩68.18 Billion ≈ $46.21 Million |
+2.29% |
| 2014-12-31 | ₩66.66 Billion ≈ $45.17 Million |
+12.78% |
| 2013-12-31 | ₩59.10 Billion ≈ $40.05 Million |
-0.79% |
| 2012-12-31 | ₩59.57 Billion ≈ $40.37 Million |
-10.85% |
| 2011-12-31 | ₩66.82 Billion ≈ $45.28 Million |
-- |
About Kukje Pharma Co Ltd
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other a… Read more